UCL trial of 6,000 prostate cancer patients found the Decipher genetic test indicates which tumours are going to spread amid ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

Having been diagnosed with prostate cancer is not the complete story. For one, it could mean that the patient’s prostate ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

LOS ANGELES, November 20, 2025--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic ...

Thousands of men with high-risk prostate cancer could soon live longer, thanks to a  test that helps doctors identify which ...

Findings from a study exploring how AI-driven NCCN guideline interpretation can optimize genetic testing and reduce clinician burden in prostate cancer. Keeping pace with rapid updates to NCCN ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...